We are live on !
Find out more
Hixon Zuercher Portfolio holdings
AUM
$347M
Turnover
10.53%
1-Year Est. Return
22.96%
This Fund
S&P 500
This Quarter Est. Return
+3.39%
1 Year Est. Return
+22.96%
3 Year Est. Return
+101.01%
5 Year Est. Return
+118.86%
10 Year Est. Return
–
AUM
$347M
AUM Growth
+$5.96M
(+1.7%)
Cap. Flow
+$1.34M
Cap. Flow % of AUM
Cap. Flow %
0.39%
Top 10 Holdings %
Top 10 Hldgs %
35.14%
Holding
95
New
7
Increased
35
Reduced
39
Closed
3
Avg Time Held
3.5
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
2.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Equity Factor ETF
LRGF
|
+$18.5M |
| 2 |
ExxonMobil
XOM
|
+$10.3M |
| 3 |
Eli Lilly
LLY
|
+$3.7M |
| 4 |
Applovin
APP
|
+$3.15M |
| 5 |
Cadence Design Systems
CDNS
|
+$1.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$12.5M |
| 2 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
+$8.06M |
| 3 |
John Hancock Multifactor Mid Cap ETF
JHMM
|
+$4.7M |
| 4 |
NextEra Energy
NEE
|
+$2.45M |
| 5 |
HCA Healthcare
HCA
|
+$2.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.77% |
| 2 | Miscellaneous | 21.18% |
| 3 | Financials | 13.17% |
| 4 | Healthcare | 8.96% |
| 5 | Communication Services | 6.86% |
Similar funds
IAS
CAM
SAMT
Hixon Zuercher's Q3 2026 Portfolio in Review
As of Q3 2026, Hixon Zuercher held 95 positions worth $347M, up 1.7% from $341M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Hixon Zuercher's Q3 2026 filing shows 7 new, 35 increased, 39 reduced and 3 closed positions. Its largest new stake was iShares US Equity Factor ETF: 239,401 shares worth $18.6M. The largest sale was Goldman Sachs ActiveBeta US Large Cap Equity ETF, an estimated $12.5M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Miscellaneous and Financials.
- Hixon Zuercher's largest Q3 2026 buy was iShares US Equity Factor ETF: 239,401 shares worth $18.6M.
- Hixon Zuercher added most to Eli Lilly in Q3 2026, an estimated $3.7M increase.
- Hixon Zuercher's biggest Q3 2026 reduction was Goldman Sachs ActiveBeta US Large Cap Equity ETF, cutting an estimated $12.5M.
- Hixon Zuercher fully exited Amdocs in Q3 2026, selling an estimated $2.07M.
- Hixon Zuercher's ten largest holdings make up 35% of its $347M portfolio in Q3 2026.
- Hixon Zuercher opened 7 new positions and closed 3 in Q3 2026.
- Hixon Zuercher's portfolio value rose 1.7% quarter-over-quarter to $347M.
Based on Hixon Zuercher's 13F filing for Q3 2026, filed 13 Oct 2026.